Loading provider…
Loading provider…
Hematology & Oncology Physician in Saint Louis, MO
NPI: 1528452240Primary Practice Location
SSM Health Saint Louis University Hospital
3635 Vista Ave, Saint Louis, MO
Primary Employer
Slucare Physician Group
ssmhealth.com
HQ Phone
Get M.D. Mhd's Phone Numberphone_androidMobile
Get M.D. Mhd's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 166 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 38 | 52 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 78 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 50 |
Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology.
Authors: Alfaseh, Ahmad, Rajeh, Mhd Nabeel, Hamed, Ghiath
Journal: Avicenna J Med
Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
Authors: Katie Schroeder, Samuel Burton, Adam Merando, Jinping Lai
Publication Date: 2017-07
Lead Sponsor: Traws Pharma, Inc.
Intervention / Treatment: DRUG: Azacitidine, DRUG: oral rigosertib
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Intervention / Treatment: OTHER: Placebo, DRUG: Rituximab, DRUG: Lenalidomide, DRUG: Brentuximab vedotin